TOBAM’s Celgene Corp CELG Stock Holding History

TOBAM’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-67,113	Closed	-$5.99M	–	181
2018 Q1	$5.99M	Sell	67,113 -10,582	-14%	-$1.02M	0.25%	88
2017 Q4	$8.11M	Buy	+77,695	New	+$8.77M	0.35%	79

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TOBAM's CELG Position: Q2 2018 in Review

TOBAM sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 67,113 shares — an estimated $5.99M sold.

TOBAM first reported a position in CELG in Q4 2017 and held it in 2 quarters. The position peaked at $8.11M in Q4 2017. 1,359 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

TOBAM reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
TOBAM sold 67,113 Celgene Corp shares in Q2 2018, an estimated $5.99M.
TOBAM first reported a position in Celgene Corp in Q4 2017 and held it in 2 quarters.
TOBAM's Celgene Corp position peaked at $8.11M in Q4 2017.
1,359 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on TOBAM's 13F filing for Q2 2018, filed 3 Aug 2018.